| Analyst / Firm | Company | Price | Rating | Price Target | Upside/Downside | Date |
|---|---|---|---|---|---|---|
Jazz Pharmaceuticals PLCJAZZ | $249.29 | Strong Buy | $300.00 | +20.34% | 19 hours ago | |
Analyst RankingTop 9% #478 out of 5499 analysts Average Return+32.98% Win Rate63%33 out of 52 Risk vs RewardPoor Good Analyst ColorDeutsche Bank's David Hoang raised their price target on Jazz Pharmaceuticals (NASDAQ: JAZZ) by 4.5% from $287 to $300 on 2026/08/26. The analyst maintained their Strong Buy rating on the stock. Hoang attributed their price target hike on Jazz Pharmaceuticals to the approval of Ziihera. | ||||||
Tesla IncTSLA | $800.00 | Strong Buy | $850.00 | +6.25% | a day ago | |
Upgrade to Premium to View MoreStrong buys: Upgrade to Premium to view the rest of today's Strong Buy stocks from Wall Street's top analysts Already have access to Premium? Sign In | ||||||